These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36434146)
1. Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clinical and therapeutic intervening study. Basu M; Mukhopadhyay D; Chakraborty B; Ghosh S; Pal DK; Ghosh A; Panda CK Mol Cell Biochem; 2023 Jul; 478(7):1599-1610. PubMed ID: 36434146 [TBL] [Abstract][Full Text] [Related]
2. Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses. Peng M; Xie J; Ucher A; Stavnezer J; Cantor SB EMBO J; 2014 Aug; 33(15):1698-712. PubMed ID: 24966277 [TBL] [Abstract][Full Text] [Related]
3. Functional and physical interaction between the mismatch repair and FA-BRCA pathways. Williams SA; Wilson JB; Clark AP; Mitson-Salazar A; Tomashevski A; Ananth S; Glazer PM; Semmes OJ; Bale AE; Jones NJ; Kupfer GM Hum Mol Genet; 2011 Nov; 20(22):4395-410. PubMed ID: 21865299 [TBL] [Abstract][Full Text] [Related]
4. Hypomethylation of mismatch repair genes MLH1 and MSH2 is associated with chemotolerance of breast carcinoma: Clinical significance. Dasgupta H; Islam S; Alam N; Roy A; Roychoudhury S; Panda CK J Surg Oncol; 2019 Jan; 119(1):88-100. PubMed ID: 30481381 [TBL] [Abstract][Full Text] [Related]
5. Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines. Hassen S; Ali AA; Kilaparty SP; Al-Anbaky QA; Majeed W; Boman BM; Fields JZ; Ali N Mol Cell Biochem; 2016 Jan; 412(1-2):297-305. PubMed ID: 26728996 [TBL] [Abstract][Full Text] [Related]
6. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484 [TBL] [Abstract][Full Text] [Related]
7. Role of MLH1 and MSH2 deficiency in the development of tumorigenesis and chemo-tolerance of cervical Carcinoma: Clinical implications. Dutta P; Pal D; Roy A; Mandal RK; Panda CK Gene; 2023 Dec; 888():147746. PubMed ID: 37657688 [TBL] [Abstract][Full Text] [Related]
8. Embryonic lethality after combined inactivation of Fancd2 and Mlh1 in mice. van de Vrugt HJ; Eaton L; Hanlon Newell A; Al-Dhalimy M; Liskay RM; Olson SB; Grompe M Cancer Res; 2009 Dec; 69(24):9431-8. PubMed ID: 19934329 [TBL] [Abstract][Full Text] [Related]
9. Mlh1 interacts with both Msh2 and Msh6 for recruitment during mismatch repair. DuPrie ML; Palacio T; Calil FA; Kolodner RD; Putnam CD DNA Repair (Amst); 2022 Nov; 119():103405. PubMed ID: 36122480 [TBL] [Abstract][Full Text] [Related]
10. Expression of mismatch repair proteins in urothelial carcinoma of the urinary bladder. Mohamedali R; Adhya AK; Mandal S; Mitra S Indian J Cancer; 2022; 59(2):279-281. PubMed ID: 35946190 [TBL] [Abstract][Full Text] [Related]
11. The First Molecular Screening of MLH1 and MSH2 Genes in Moroccan Colorectal Cancer Patients Shows a Relatively High Mutational Prevalence. Moufid FZ; Bouguenouch L; El Bouchikhi I; Chbani L; Iraqui Houssaini M; Sekal M; Belhassan K; Bennani B; Ouldim K Genet Test Mol Biomarkers; 2018 Aug; 22(8):492-497. PubMed ID: 30044143 [TBL] [Abstract][Full Text] [Related]
12. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers]. Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605 [No Abstract] [Full Text] [Related]
14. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032 [TBL] [Abstract][Full Text] [Related]
15. The properties of Msh2-Msh6 ATP binding mutants suggest a signal amplification mechanism in DNA mismatch repair. Graham WJ; Putnam CD; Kolodner RD J Biol Chem; 2018 Nov; 293(47):18055-18070. PubMed ID: 30237169 [TBL] [Abstract][Full Text] [Related]
16. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma. Stark AM; Doukas A; Hugo HH; Hedderich J; Hattermann K; Maximilian Mehdorn H; Held-Feindt J Neurol Res; 2015 Feb; 37(2):95-105. PubMed ID: 24995467 [TBL] [Abstract][Full Text] [Related]
17. Methylation Tolerance-Based Functional Assay to Assess Variants of Unknown Significance in the MLH1 and MSH2 Genes and Identify Patients With Lynch Syndrome. Bouvet D; Bodo S; Munier A; Guillerm E; Bertrand R; Colas C; Duval A; Coulet F; Muleris M Gastroenterology; 2019 Aug; 157(2):421-431. PubMed ID: 30998989 [TBL] [Abstract][Full Text] [Related]
18. Reduced expression of mutS homolog 2 and mutL homolog 1 affects overall survival in laryngeal squamous cell carcinoma patients: Investigation into a potential cause. Gong HL; Shi Y; Shi Y; Wu CP; Cao PY; Zhou L; Xu C Oncol Rep; 2013 Sep; 30(3):1371-9. PubMed ID: 23787767 [TBL] [Abstract][Full Text] [Related]
19. Expression of DNA mismatch repair proteins and MSH2 polymorphisms in nonmelanoma skin cancers of organ transplant recipients. Perrett CM; Harwood CA; McGregor JM; Warwick J; Cerio R; Karran P Br J Dermatol; 2010 Apr; 162(4):732-42. PubMed ID: 19818066 [TBL] [Abstract][Full Text] [Related]
20. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma. Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]